Ketamine is rapidly gaining attention as a legitimate treatment for depression, PTSD, and chronic pain. While traditionally used as an anesthetic, its off-label therapeutic benefits have driven significant growth in ketamine infusion clinics and home-treatment...

In recent months, the New York State Office of the Medicaid Inspector General (OMIG) has ramped up the issuance of Medicaid enrollment denials for providers seeking to be enrolled in the New York State Medicaid Program. These denials are often based on vague or...

ph Recent developments suggest that significant efforts to curb abuses and harmful practices of Pharmacy Benefit Managers (PBMs) may be on the horizon. Both the Federal Trade Commission (FTC) and major media outlets have increased scrutiny on PBM practices,...

The Corporate Transparency Act (CTA) is a new law that affects small businesses in the U.S., including LLCs, corporations, and professional entities. Its main purpose is to help stop illegal activities like money laundering by making business ownership more...

We would like to remind New York healthcare providers about a significant regulatory aspect that impacts the way private insurers handle medical necessity disputes in New York. This is particularly relevant for those engaged in dealing with insurance audits or...

Recently, home infusion pharmacies have faced formidable challenges stemming from underpayment, untimely payment, and non-payment by major medical plans for infusion therapies. This pervasive issue affects both in-network and out-of-network providers across the...